These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 10908767)
1. Endoglin expression as a measure of microvessel density in cervical cancer. Brewer CA; Setterdahl JJ; Li MJ; Johnston JM; Mann JL; McAsey ME Obstet Gynecol; 2000 Aug; 96(2):224-8. PubMed ID: 10908767 [TBL] [Abstract][Full Text] [Related]
3. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457 [TBL] [Abstract][Full Text] [Related]
4. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950 [TBL] [Abstract][Full Text] [Related]
5. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Behrem S; Zarkovic K; Eskinja N; Jonjic N Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360 [TBL] [Abstract][Full Text] [Related]
8. Significance of CD 105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Salvesen HB; Gulluoglu MG; Stefansson I; Akslen LA APMIS; 2003 Nov; 111(11):1011-8. PubMed ID: 14629267 [TBL] [Abstract][Full Text] [Related]
9. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949 [TBL] [Abstract][Full Text] [Related]
10. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
11. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
13. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132 [TBL] [Abstract][Full Text] [Related]
14. Endoglin (CD105) is expressed on immature blood vessels and is a marker for survival in prostate cancer. Wikström P; Lissbrant IF; Stattin P; Egevad L; Bergh A Prostate; 2002 Jun; 51(4):268-75. PubMed ID: 11987155 [TBL] [Abstract][Full Text] [Related]
15. Analysis of neovasculature in uveal melanoma by targeting the TGFbeta-binding receptor endoglin: is there prognostic relevance of proliferating endothelium? Ziemssen F; Wegner R; Wegner J; Tatar O; Süsskind D; Gelisken F; Rohrbach M; Bartz-Schmidt KU; Grisanti S Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1124-31. PubMed ID: 16523306 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. Ho JW; Poon RT; Sun CK; Xue WC; Fan ST World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823 [TBL] [Abstract][Full Text] [Related]
18. Microvessel Landscape Assessment in Pancreatic Ductal Adenocarcinoma: Unclear Value of Targeting Endoglin (CD105) as Prognostic Factor of Clinical Outcome. Lytras D; Leontara V; Kefala M; Foukas PG; Giannakou N; Pouliakis A; Dervenis C; Panayiotides IG; Karakitsos P Pancreas; 2015 Jan; 44(1):87-92. PubMed ID: 25058886 [TBL] [Abstract][Full Text] [Related]
19. Endoglin as a marker in cervical paragangliomas. Eleno N; Düwel A; Muñoz A; Paz-Bouza J; López-Novoa JM; Lozano F Head Neck; 2010 Jun; 32(6):737-43. PubMed ID: 19827102 [TBL] [Abstract][Full Text] [Related]
20. CD105 microvessels density, VEGF, EGFR-1 and c-erbB-2 and their prognostic correlation in different subtypes of cervical adenocarcinoma. Barbu I; Crăiţoiu S; Simionescu CE; Drâgnei AM; Mărgăritescu C Rom J Morphol Embryol; 2013; 54(3):519-30. PubMed ID: 24068399 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]